Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders.
暂无分享,去创建一个
C. Hoebe | L. Visser | C. V. Van Jaarsveld | I. V. van Loo | A. Vossen | G. Boland | C. Beulens | S. Raven
[1] A. Dibernardo,et al. Stability of SARS-CoV-2 IgG in multiple laboratory conditions and blood sample types , 2021, Journal of Clinical Virology.
[2] Luisa Ganfini,et al. Effect of Repeated Freeze–Thaw Cycles on Influenza Virus Antibodies , 2021, Vaccines.
[3] Gheyath K Nasrallah,et al. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies , 2020, International Journal of Infectious Diseases.
[4] Dongmu Zhang,et al. Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study , 2019, BMC Public Health.
[5] C. Hoebe,et al. Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial. , 2019, The Lancet. Infectious diseases.
[6] S. Kurosky,et al. Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States. , 2018, Vaccine.
[7] P. Easterbrook,et al. Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers , 2017, BMC Infectious Diseases.
[8] C. Hoebe,et al. Diagnostic performance of serological assays for anti-HBs testing: Results from a quality assessment program. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[9] F. Cutts,et al. Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low‐ and middle‐income countries , 2016, Tropical medicine & international health : TM & IH.
[10] C. Lau,et al. A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination. , 2015, Vaccine.
[11] Li Li,et al. Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China , 2015, Human vaccines & immunotherapeutics.
[12] Yi Feng,et al. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up]. , 2015, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].
[13] C. Hoebe,et al. High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[14] C. Hoebe,et al. Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders. , 2012, Vaccine.
[15] U. Heininger,et al. Successful hepatitis B immunization in non- and low responding health care workers , 2010, Human vaccines.
[16] J. Nelson,et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. , 2009, American journal of public health.
[17] A. Frydén,et al. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. , 2008, The Journal of infectious diseases.
[18] D. Neumann-Haefelin,et al. Comparison of Nine Commercially Available Assays for Quantification of Antibody Response to Hepatitis B Virus Surface Antigen , 2008, Journal of Clinical Microbiology.
[19] G. Drusano,et al. Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response. , 2003, Vaccine.
[20] P. Wollan,et al. Effect of Multiple Freeze-Thaw Cycles on Detection of Measles, Mumps, and Rubella Virus Antibodies , 2003, Clinical Diagnostic Laboratory Immunology.
[21] K. Leder,et al. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] G. Moens,et al. The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population. , 2002, Vaccine.
[23] H. Whittle,et al. What level of hepatitis B antibody is protective? , 1999, The Journal of infectious diseases.
[24] B. McMahon,et al. Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study. , 1997, The Journal of infectious diseases.
[25] S. Hadler,et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. , 1986, The New England journal of medicine.